Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). (Q41962159)
Jump to navigation
Jump to search
scientific article published on 19 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). |
scientific article published on 19 May 2014 |
Statements
1 reference
Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). (English)
1 reference
Tomoya Kawaguchi
1 reference
Masahiko Ando
1 reference
Kazuhiro Asami
1 reference
Yoshio Okano
1 reference
Masaaki Fukuda
1 reference
Hideyuki Nakagawa
1 reference
Hidenori Ibata
1 reference
Toshiyuki Kozuki
1 reference
Takeo Endo
1 reference
Atsuhisa Tamura
1 reference
Mitsuhiro Kamimura
1 reference
Kazuhiro Sakamoto
1 reference
Michihiro Yoshimi
1 reference
Yoshifumi Soejima
1 reference
Yoshio Tomizawa
1 reference
Shun-ichi Isa
1 reference
Minoru Takada
1 reference
Hideo Saka
1 reference
Akihito Kubo
1 reference
19 May 2014
1 reference
1 reference
32
1 reference
18
1 reference
1902-1908
1 reference
Identifiers
1 reference
1 reference